is lemme glp 1 the same as ozempic GLP-1 Daily: Supresa-Based GLP-1 Support from Kourtney Kardashian Abbey Sharp • Registered Dietitian

Medical oversight and secure messaging support are included in the monthly price

Which Medication Should You Choose

With over 40% of American adults estimated to have obesity, this disease poses significant health risks, including heart disease, stroke, and type 2 diabetes

Several GLP-1 agonists have FDA approval for other indications that may overlap with BED patient populations: Semaglutide (Wegovy) and liraglutide (Saxenda) are approved for chronic weight management in adults with obesity (BMI 30) or overweight (BMI 27) with at least one weight-related comorbidity Semaglutide (Ozempic), liraglutide (Victoza), dulaglutide (Trulicity), and tirzepatide (Mounjaro) are approved for type 2 diabetes management Tirzepatide (Zepbound) is approved for chronic weight management When clinicians prescribe GLP-1 agonists for BED, this constitutes off-label use a legal and common practice in medicine when evidence suggests potential benefit and approved treatments are inadequate